F2 and hyperhomocysteinemia: Patients with the aforementioned conditions are frequently screened for the presence of APCR, prothrombin gene mutation, antiphospholipid antibodies, hyperhomocysteinemia, and protein C and S, and antithrombin deficiency; however, SPS is not routinely included in screening for thrombophilia.